Return to search

Aptuit Buying Evotec Unit

Aptuit Inc., a Greenwich, Conn.-based provider of streamlining and support services for drug developers, has agreed to acquire the chemical development business of Evotec AG (Frankfurt: EVT). The deal is valued at approximately EUR46.4 million in cash, and includes Evotec's capabilities in process R&D, custom preparation, analytical development, pilot plant manufacturing and formulation. Aptuit said that it intends to retain all of the businesses 210 employees, who are split between Oxford and Glasgow, UK. Aptuit is backed by Welsh, Carson, Anderson & Stowe and Temasek Holdings. www.aptuit.com www.ssci-inc.com